Related Experiment Video

Updated: Jul 9, 2025

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

15.8K

Overview of current melanoma therapies

Anna Fateeva1,2, Kevinn Eddy1,2, Suzie Chen1,2,3

  • 1Susan Lehman Cullman Laboratory for Cancer Research, Rutgers University, Piscataway, New Jersey, USA.

Pigment Cell & Melanoma Research
|December 8, 2023
PubMed

Insights

Melanoma, an aggressive skin cancer, has seen improved outcomes with new targeted therapies and immunotherapies. However, treatment resistance and relapse remain significant challenges, limiting therapeutic options.

Area of Science:

  • Oncology
  • Dermatology
  • Cancer Research

Background:

  • Melanoma is the most lethal form of skin cancer.
  • Recent advances include targeted therapies and immunotherapies.
  • Treatment resistance and cancer recurrence remain critical issues.

Purpose of the Study:

  • To review current therapeutic options for melanoma.
  • To discuss the benefits of existing treatments.
  • To highlight the limitations of current melanoma therapies.

Main Methods:

  • Literature review of melanoma treatments.
  • Analysis of targeted therapy efficacy.
  • Evaluation of immunotherapy outcomes.

Main Results:

  • Targeted therapies and immunotherapies have improved melanoma patient outcomes.
  • Acquired resistance to these treatments is a significant clinical problem.
  • Melanoma relapse after initial treatment is common.

Conclusions:

  • Despite advances, melanoma treatment remains challenging due to resistance and relapse.
  • Further research is needed to overcome therapeutic limitations.
  • Optimizing current strategies and developing novel approaches are crucial for improving survival rates.
Keywords:
drug resistanceimmunotherapymelanomametabotropic glutamate receptor type 1molecular targeted therapyriluzoleskin neoplasms

More Related Videos

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation05:33

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Published on: September 6, 2024

1.5K
A Melanoma Patient-Derived Xenograft Model07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

12.4K

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.2K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
376
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K